Rothschild & Co Redburn upgraded Colgate-Palmolive (CL) to Buy from Neutral with a price target of $100, up from $93. The firm says its analysis of the home and personal care space following the recent selloff yields a favorable outlook for Colgate. The company offers “resilient growth” and has “strong track record” on driving pricing and productivity savings, the analyst tells investors in a research note. In addition, Rothschild says the stock’s absolute and relative valuation is below multi-year average levels.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of April 20, 2026
- The Week That Was, The Week Ahead: Macro and Markets, April 19
- Colgate-Palmolive price target lowered to $95 from $97 at JPMorgan
- Colgate-Palmolive price target lowered to $79 from $88 at Barclays
- Colgate-Palmolive price target lowered to $102 from $105 at BofA